PO.ET08.03 · 实验与分子治疗

A universal duplex sequencing approach for accurate detection of somatic mutations

海报缩略图:A universal duplex sequencing approach for accurate detection of somatic mutations
编号 7205 展板 24 时间 4/22 09:00–12:00 区域 Section 17 主讲 Shuvro Prokash Nandi, BS;MS;PhD
分会场 Targeted Radiopharmaceuticals and Combination Strategies in Cancer Therapy
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Shuvro Prokash Nandi1, Yuhe Cheng2, Shams Al-azzam3, Safa Saeed2, Isabella R Stuewe1, Zichen Jiang2, Luka Culibrk4, Maria Zhivagui5, Xiaoxu Yang6, Rachel M. Wise7, Foster C. Jacobs8, Bérénice Chavanel9, Michael Korenjak9, Mia PETLJAK10, Silvia Balbo11, Laurie G. Hudson12, Ke Jian Liu13, Jiri Zavadil9, Joseph G. Gleeson14, Ludmil B. Alexandrov3

1Cellular and Molecular Medicine, UCSD Moores Cancer Center, La Jolla, CA,2UCSD, La Jolla, CA,3UC San Diego Health, San Diego, CA,4Department of Pathology, Grossman Medical School, New York, NY,5University of Nevada, Las Vegas (UNLV), Las Vegas, NV,6Department of Human Genetics, University of Utah, Salt Lake City, UT,7Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM,8University of Minnesota, Minneapolis, MN,9International Agency for Research on Cancer WHO, Lyon, France,10NYU Langone Health, New York, NY,11Postdoctoral Fellow, Masonic Cancer Ctr., University of Minnesota Masonic Cancer Center, Minneapolis, MN,12Professor, Dept. of Pharmaceutical Sci., Univ. of New Mexico Health Sciences Ctr., Albuquerque, NM,13Stony Brook Cancer Center, Stony Brook, NY,14Rady Children’s Institute for Genomic Medicine, San Diego, CA

摘要 Abstract

Somatic mutations arise from endogenous and exogenous mutagenic processes, accumulating over time and contributing to aging and disease. Detecting these rare mutations in non-clonal tissues remains a significant challenge due to the high error rates, limited genome coverage, and substantial DNA input requirements of existing sequencing approaches. Here, we introduce UDSeq, a high-accuracy, cost-effective, single-molecule duplex sequencing protocol designed to overcome these limitations. We place UDSeq in the context of existing duplex sequencing approaches, demonstrating that it achieves an exceptionally low error rate of ~2.5 × 10 -9 per base pair, supports whole-genome and targeted capture sequencing from as little as 100 picograms of DNA, and delivers up to four times more usable duplex molecules than current state-of-the-art methods from the same input. We demonstrated the broad applicability of UDSeq through a series of in vitro and in vivo mutagenesis experiments, accurately capturing known mutational signatures induced by environmental carcinogens in human cell lines, rodents, and non-model organisms. We further applied UDSeq to normal tissues from a 70-year-old individual, revealing organ-specific mutational burdens and the activity of distinct mutational processes. With its high accuracy, low input requirements, and wide applicability, UDSeq provides a powerful and scalable tool for studying mutational processes across diverse biological contexts. Its versatility supports applications in cancer research, aging, and environmental exposure, expanding our capacity to characterize somatic mutations in both healthy and diseased tissues.
利益披露 Disclosure
S. Nandi, None.. S. Saeed, None.. I. Stuewe, None.. L. Culibrk, None.. X. Yang, None.. R. Wise, None.. F. Jacobs, None.. B. Chavanel, None.. M. Korenjak, None.. K. Liu, None.. J. Zavadil, None.. J. Gleeson, None.

在会议检索中打开